Authors: Bordin, V Giani, L Meregalli, S Bukovec, R Vaghi, MM Mandala, M Paolorossi, F Ardizzoia, A Tancini, G Barni, S Frigerio, F Fumagalli, L Bordoni, A Valusani, G Di Felice, G Lissoni, P

Citation: V. Bordin et al., Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients, UROL INTERN, 64(1), 2000, pp. 3-8